Nanosecond-laser application in intermediate AMD: 12-month results of fundus appearance and macular function

Clinical and Experimental Ophthalmology

Volumn 42, Issue 5, 2014, Pages 466-479

  Guymer, Robyn H ^a   Brassington, Kate H ^a   Dimitrov, Peter ^a   Makeyeva, Galina ^a   Plunkett, Malcolm ^b   Xia, Wie ^b   Chauhan, Devinder ^a   Vingrys, Algis ^a   Luu, Chi D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Ellex Medical Lasers R and D   (Australia)

Author keywords

AMD; Macula; Nanosecond laser; Perimetry

Indexed keywords

ABSENCE OF COMPLICATIONS; ADULT; AGED; ARTICLE; ATROPHY; CENTRAL RETINAL THICKNESS; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL FLICKER FUSION; DEVICE SAFETY; DRUSEN; EYE FUNDUS; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; GEOGRAPHIC ATROPHY; HIGH RISK PATIENT; HUMAN; INTERVENTION STUDY; LOW LEVEL LASER THERAPY; MALE; NANODEVICE; OPHTHALMIC LASER; OPHTHALMIC NANOSECOND LASER; OUTCOME ASSESSMENT; PERIMETRY; PILOT STUDY; PROSPECTIVE STUDY; REJUVENATION; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; TREATMENT OUTCOME; TREATMENT RESPONSE; VISION; VISUAL ACUITY; MACULAR DEGENERATION; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROGNOSIS; RETINA; VERY ELDERLY; VISUAL FIELD;

AGED; AGED, 80 AND OVER; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INTERVENTION STUDIES; LASER THERAPY, LOW-LEVEL; MACULAR DEGENERATION; MALE; MIDDLE AGED; PILOT PROJECTS; PROGNOSIS; PROSPECTIVE STUDIES; RETINA; RETINAL DRUSEN; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VISUAL FIELD TESTS; VISUAL FIELDS;

EID: 84904694595     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/ceo.12247     Document Type: Article

References (39)

1. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001; 119: 1417-1436.
2. Age-Related Eye Disease Study 2 Research Group. Lutein zeaxanthin and omega-3 fatty acids for age-related macular degeneration the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA 2013; 309: 2005-2015.
3. Adams MKM, Simpson JA, Aung KZ etal. Abdominal obesity and age-related macular degeneration. Am J Epidemiol 2011; 173: 1246-1255.
4. Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 1983; 220: 524-527.
5. Roider J, Birngruber R. Spatial Confinement of Photocoagulation Effects Using High Repetition Rate Laser Pulses. 'In:' Technical Digest Series of Conference on Lasers and Electro-Optics. Washington, DC: Optical Society of America, 1990.
6. Brinkmann R, Huttmann G, Rogener J, Roider J, Birngruber R, Lin CP. Origin of retinal pigment epithelium cell damage by pulsed laser irradiance in the nanosecond to microsecond time regimen. Lasers Surg Med 2000; 27: 451-464.
7. Wood JP, Plunkett M, Previn V, Chidlow G, Casson RJ. Nanosecond pulse lasers for retinal applications. Lasers Surg Med 2011; 43: 499-510.
8. Wood JP, Shibeeb O, Plunkett M, Casson RJ, Chidlow G. Retinal damage profiles and neuronal effects of laser treatment: comparsion of a conventional photocoagulator and a novel 3-nanosecond pulse laser. Invest Ophthalmol Vis Sci 2013; 54: 2305-2318.
9. Chidlow G, Shibeeb O, Plunkett M, Casson RJ, Wood JP. Glial cell and inflammatory responses to retinla laser treatment: comparsion of a conventional photocoagulator and a novel 3-nanosecond pulse laser. Invest Ophthalmol Vis Sci 2013; 54: 2319-2332.
10. Zhang JJ, Sun Y, Hussain AA, Marshall J. Laser mediated activation of human retinal pigment epithelial (RPE) cells and concomitant release of matrix metalloproteinases (MMPs). Invest Ophthalmol Vis Sci 2012; 53: 2928-2937.
11. Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol 2008; 146: 496-500.
12. Lois N, Owens SL, Coco R, Hopkins J, Fitzke FW, Bird AC. Fundus autofluorescence in patients with age-related macular degeneration and high risk of visual loss. Am J Ophthalmol 2002; 133: 341-349.
13. Siderov J, Tiu AL. Variability of measurements of visual acuity in a large eye clinic. Acta Ophthalmol Scand 1999; 77: 673-676.
14. Zele AJ, Dang TM, O'Loughlin RK, Guymer RH, Harper A, Vingrys AJ. Adaptation mechanisms, eccentricity profiles, and clinical implementation of red-on-white perimetry. Optom Vis Sci 2008; 85: 309-317.
15. Hogg RE, Chakravarthy U. Visual function and dysfunction in early and late age-related maculopathy. Prog Retin Eye Res 2006; 25: 249-276.
16. Dimitrov PN, Guymer RH, Zele AJ, Anderson AJ, Vingrys AJ. Measuring rod and cone dynamics in age-related maculopathy. Inves Ophthalmol Vis Sci 2008; 49: 55-65.
17. Mayer MJ, Ward B, Klein R, Talcott JB, Dougherty RF, Glucs A. Flicker sensitivity and fundus appearance in pre-exudative age-related maculopathy. Invest Ophthalmol Vis Sci 1994; 35: 1138-1149.
18. Owsley C, Jackson GR, White M, Feist R, Edwards D. Delays in rod-mediated dark adaptation in early age-related maculopathy. Ophthalmology 2001; 108: 1196-1202.
19. Phipps JA, Guymer RH, Vingrys AJ. Temporal sensitivity deficits in patients with high-risk drusen. Aust N Z J Ophthalmol 1999; 27: 265-267.
20. Phipps JA, Guymer RH, Vingrys AJ. Loss of cone function in age-related maculopathy. Inves Ophthalmol Vis Sci 2003; 44: 2277-2283.
21. Chen JC, Fitzke FW, Pauleikhoff D, Bird AC. Functional loss in age-related Bruch's membrane change with choroidal perfusion defect. Invest Ophthalmol Vis Sci 1992; 33: 334-340.
22. Eisner A, Stoumbos VD, Klein ML, Fleming SA. Relations between fundus appearance and function. Eyes whose fellow eye has exudative age-related macular degeneration. Invest Ophthalmol Vis Sci 1991; 32: 8-20.
23. Mayer MJ, Spiegler SJ, Ward B, Glucs A, Kim CB. Mid-frequency loss of foveal flicker sensitivity in early stages of age-related maculopathy. Invest Ophthalmol Vis Sci 1992; 33: 3136-3142.
24. Mayer MJ, Spiegler SJ, Ward B, Glucs A, Kim CB. Foveal flicker sensitivity discriminates ARM-risk from healthy eyes. Invest Ophthalmol Vis Sci 1992; 33: 3143-3149.
25. Phipps JA, Dang TM, Vingrys AJ, Guymer RH. Flicker perimetry losses in age-related macular degeneration. Invest Ophthalmol Vis Sci 2004; 45: 3355-3360.
26. Dimitrov PN, Robman LD, Varsamidis M etal. Visual function tests as potential biomarkers in age-related macular degeneration. Invest Ophthalmol Vis Sci 2011; 52: 9457-9469.
27. Dimitrov PN, Robman LD, Varsamidis M etal. Relationship between clinical macular changes and retinal function in age-related macular degeneration. Invest Ophthalmol Vis Sci 2012; 53: 5213-5220.
28. Luu C, Dimitrov P, Robman L etal. The role of flicker perimetry in predicting onset of late stage age-related macular degeneration. Arch Ophthalmol 2012; 130: 690-699.
29. Ferris FL, Davis MD, Clemons TE etal. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol 2005; 123: 1570-1574.
30. Ferris FL, Wilkinson CP, Bird A etal., on behalf of the Beckman Initiative for Macular Research Classification Committee. Clinical classification of age-related macular degeneration. Ophthalmology 2013; 120: 844-851.
31. Vingrys A, Demirel S, Kalloniatis M. Multi-dimensional color, flicker and increment perimetry. In: Mills R, Wall M, eds. Perimetry Update 1994/95. Amsterdam: Kugler Publications, 1995; 159-166.
32. McKendrick AM, Vingrys AJ, Badcock DR, Heywood JT. Visual field losses in subjects with migraine headaches. Invest Ophthalmol Vis Sci 2000; 41: 1239-1247.
33. Landers J, Sharma A, Goldberg I, Graham S. A comparison of perimetric results with the Medmont and Humphrey perimeters. Br J Ophthalmol 2003; 87: 690-694.
34. Yehoshua Z, Wang F, Rosenfeld PJ, Penha FM, Feuer WJ, Gregori G. Natural history of drusen morphology in age-related macular degeneration using spectral domain optical coherence tomography. Ophthalmology 2011; 118: 2434-2441.
35. Nittala MG, Ruiz-Garcia H, Sadda SR. Accuracy and reproducibility of automated drusen segmentation in eyes with non-neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2012; 53: 8319-8324.
36. Casson RJ, Raymond G, Newland HS, Gilhotra JS, Gray TL. Pilot randomized trial of a nanopulse retinal laser versus conventional photocoagulation for the treatment of diabetic macular oedema. Clin Exp Ophthalmol 2012; 40: 604-610.
37. Rhodes KM, Weinstein R, Saltzmann RM etal. Intraocular pressure reduction in the untreated fellow eye after selective laser trabeculoplasty. Curr Med Res Opin 2009; 25: 787-796.
38. Qiao H, Lucas K, Stein-Streilein J. Retinal laser burn disrupts immune privilege in the eye. Am J Pathol 2009; 174: 414-422.
39. Xu H, Chen M, Forrester JV. Para-inflammation in the aging retina. Prog Retin Eye Res 2009; 28: 348-368.